March 04, 2019
Fusion Pharmaceuticals Announces Appointment Of John J. Crowley As Chief Financial Officer
Media
February 27, 2019
Aprea Therapeutics Adds New Investor to Series C Financing
February 27, 2019
BONESUPPORT HOLDING AB (publ) – Full Year Report 2018
February 27, 2019
Nordic Nanovector ASA – Results for the Fourth Quarter and Full Year 2018
February 27, 2019
Data from Oncopeptides Clinical Trials HORIZON and ANCHOR Evaluating Melflufen in RRMM Selected for Presentation at the AACR Annual Meeting
February 26, 2019
Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2018 Financial Results
February 25, 2019
GenSight Biologics completes a capital increase of €8 million without discount subscribed entirely by Sofinnova
February 22, 2019
Modus announces First Cohort Dosed in U.S. Phase 1 Study of Subcutaneously Administered Sevuparin
February 22, 2019
BONESUPPORT – Publication of a clinical study highlighting Vancomycin release from CERAMENT® V in major hip surgery
February 22, 2019
Oncopeptides Year-end Report 2018